Assessment of VILI risk in mechanically ventilated patients is commonly done based on information such as the ventilator settings and measured pressure and airflow. However, these provide global information on the operation of the lungs as a whole. Patients with lung abnormalities such as consolidations, atelectasis, chronic obstructive pulmonary disease (COPD), or acute respiratory distress syndrome (ARDS) often show regional variations in lung resistance and compliance. The affected parts of the lung with a low compliance may show tidal recruitment (i.e., a repetitive opening and closing of collapsed alveoli during the mechanical respiratory cycle). The resultant high tissue stress in these atelectatic zones can trigger a local inflammatory response and injure the alveolar-capillary membrane called atelectotrauma which potentially can lead to ventilator-induced lung injury (VILI), impairing the outcome of these patients. Measurement of global lung parameters may fail to detect these more localized regional stresses. When mechanically ventilated, these patients may benefit from lung recruitment maneuvers and higher Positive End-Expiratory Pressure (PEEP) levels to avoid atelectotrauma by maintaining consistent lung opening of the parts of the lung with a low compliance. However, this may result in regional overdistension in those (healthy) parts of the lung having a high compliance, which is another mechanism of VILI, impairing the outcome of patients.
For these patients, the use of advanced imaging techniques can help to determine a lung protective ventilation strategy. Currently, computed tomography (CT) scanning is preferred to obtain reliable regional information by measuring the difference in aeration observed between static images taken at end-inspiration and end-expiration. However, this method is time consuming, exposes the patient to radiation, and cannot be applied at the bedside. Another technique to obtain regional lung information is Electrical Impedance Tomography (EIT). However, also this technique is expensive and not widely accessible.
Another solution to obtain regional lung information is the use of lung ultrasound (LUS), a subclass of diagnostic ultrasound. For example, a BLUE protocol (see, e.g., Lichtenstein D A et al. Relevance of lung ultrasound in the diagnosis of acute respiratory failure: the BLUE protocol. Chest. 2008; Lichtenstein, D. A. Lung ultrasound in the critically ill. Ann. Intensive Care 4, 2014) allows for diagnosis of acute respiratory failure at the bedside by assessing and scoring for each lung zone a multitude of ‘signs’ in the ultrasound image. Each sign or a combination of signs is associated with a lung disorder (e.g., the presence of B-lines in combination with lung rockets indicating interstitial syndrome). Also, LUS can be used to assess tidal recruitment Tusman G, et al. Real-time images of tidal recruitment using lung ultrasound. Crit Ultrasound J. 2015).
An interesting lung phenomenon that can be visualized by LUS is lung sliding, which is the sliding back and forth of the visceral and parietal pleura relative to one another as the patient breathes. Lung sliding can be assessed qualitatively by ultrasound at the anterior, lateral, and posterior chest and is mainly used for the diagnosis of pneumothorax. Recent advances in ultrasound image processing such as speckle tracking allow for quantification of lung sliding (see, e.g., G. Duclos et al. “Speckle tracking quantification of lung sliding for the diagnosis of pneumothorax: A multicentric observational study”, Intensive Care Med. 2019; G. Duclos et al. “A picture's worth a thousand words: Speckle tracking for quantification and assessment of lung sliding”, Intensive care med. 2019; E. Fissore et al. “Pneumothorax diagnosis with lung sliding quantification by speckle tracking: A prospective multicentric observational study”, The American journal of emergency medicine 2021; and L. Crognier et al. “Diaphragmatic speckle tracking imaging for 2D-strain assessment in mechanical ventilation weaning test”, Medical hypotheses 2021). These speckles are acoustic markers which are formed by interference of ultrasound waves that are scattered from physical structures of a size comparable to the wavelength of the ultrasound waves. In some examples, a measure for lung sliding is obtained by calculating the average temporal intensity changes of the ultrasound speckles in the pleural line. This results in an Intensity Based Speckle Tracking (IBST) score waveform which correlates well with the ventilator flow waveform.
Another method to obtain information on presence of tidal recruitment and overdistension is to analyse the shape of the pressure-time curve. For constant flow and in the absence of respiratory muscle activity, the status of the lung can be assessed by defining a stress index based on the concavity of the pressure-time curve. However, this can only be done on a global basis and not for specific parts of the lung.
Yet another method to obtain information on presence of atelectasis and overdistension is to analyse the shape of the pressure-volume (P-V) loop, using the pressure at the wye or using transpulmonary pressure e.g., derived from esophageal pressure measurements. Here, depending on the shape of the P-V loop zones of overdistension as one option, and decruitment and atelectasis as the other option can be distinguished. Again, only global information on the lungs is thusly obtained. The method based on the transpulmonary pressure is more accurate but not always available at the bedside.
Another method to guide a lung protective ventilation strategy is based on assessment of lung resistance and compliance. Methods to assess global lung resistance and compliance exist. These methods are based on dedicated ventilator maneuvers to obtain the parameters needed to solve an element model for lung resistance and compliance. However, since it is difficult to estimate the respiratory drive, these methods only work for a passive patient, i.e., Pmus=0 cmH2O. Moreover, these methods only work for global resistance and compliance and cannot give a good approximation of regional variations in lung resistance and compliance, and hence of regional tidal recruitment and overdistension.
The following discloses certain improvements to overcome these problems and others.
In one aspect, a mechanical ventilation device includes an electronic controller configured to: receive imaging data and ventilator data associated with lungs of a patient while the patient undergoes mechanical ventilation therapy with an associated mechanical ventilator; determine a respiratory pressure of the patient based at least on the received ventilator data; determine a lung volume and a lung flow for at least one region of the lungs based on lung sliding data determined from the received imaging data and the determined respiratory pressure; determine a regional resistance and elastance for the at least one region of the lungs from the lung volume and the lung flow for the at least one region; and display the regional resistance and elastance for the at least one region of the lungs on a display device.
In another aspect, a mechanical ventilation method includes, with an electronic controller: receiving imaging data and ventilator data associated with lungs of a patient while the patient undergoes mechanical ventilation therapy with an associated mechanical ventilator; determining a respiratory pressure of the patient based at least on the received ventilator data; determining a lung volume and a lung flow for at least one region of the lungs based on lung sliding data determined from the received imaging data and the determined respiratory pressure; determining a regional resistance and elastance for the at least one region of the lungs from the lung volume and the lung flow for the at least one region; and displaying the regional resistance and elastance for the at least one region of the lungs on a display device.
One advantage resides in providing regional lung information in a quick, accessible manner.
Another advantage resides in providing regional lung information without the use of CT imaging or EIT processes.
Another advantage resides in providing regional lung information for a patient who is providing an active respiratory effort.
Another advantage resides in providing regional lung information based on lung sliding measurements.
Another advantage resides in preventing VILI.
A given embodiment may provide none, one, two, more, or all of the foregoing advantages, and/or may provide other advantages as will become apparent to one of ordinary skill in the art upon reading and understanding the present disclosure.
The disclosure may take form in various components and arrangements of components, and in various steps and arrangements of steps. The drawings are only for purposes of illustrating the preferred embodiments and are not to be construed as limiting the disclosure.
As used herein, the singular form of “a”, “an”, and “the” include plural references unless the context clearly dictates otherwise. As used herein, statements that two or more parts or components are “coupled,” “connected,” or “engaged” shall mean that the parts are joined, operate, or co-act together either directly or indirectly, i.e., through one or more intermediate parts or components, so long as a link occurs. Directional phrases used herein, such as, for example and without limitation, top, bottom, left, right, upper, lower, front, back, and derivatives thereof, relate to the orientation of the elements shown in the drawings and are not limiting upon the scope of the claimed invention unless expressly recited therein. The word “comprising” or “including” does not exclude the presence of elements or steps other than those described herein and/or listed in a claim. In a device comprised of several means, several of these means may be embodied by one and the same item of hardware.
Disclosed herein are systems and methods to support bedside clinicians and care providers in providing safe mechanical ventilation, including guiding clinicians in selecting ventilator settings that will not produce VILI in the specific patient.
With reference to
With brief reference to
With particular reference to
Referring back now to
P
ao(t−Pmus(t)−RregionalVregional(t)+EregionalVregional(t)+P0 (1)
wherein Pao(t) [cm H2O] is a pressure at an airway opening (i.e., the mouth), Pmus(t) [cm H2O] is a pressure equivalent to an action of respiratory muscles, Rregional [cm H2O*s/L] is a resistance of the respiratory system, Vregional(t) [L/s] is a gas (air plus oxygen) flow through the airways, Eregional ([cm H2O/L] is an elastance of the respiratory system (where a compliance Cregional of the respiratory system is defined as 1/Eregional), and Vregional(t) (L) is a volume of inhaled gas and P0 is a constant term that can be estimated at any point at the end of the breath where the gas flow is zero and Pmus(t) is zero (at which point P0 will be equal to Pao). The difference between Pao(t) and Pmus(t) can be referred to as a driving pressure. The product of RregionalVregional(t) can be referred to as a resistive work. The product of EregionalVregional(t) can be referred to as elastic work. Equation 1 is a localized version of an equation of motion and assumes a driving pressure being the same for all regions of the lung.
In another example, to refine Equation 1, the elastance Eregional is split into an elastance of the lung El,regional and an elastance of the chest wall Ecw,regional. This allows the electronic controller 13 to solve for the transpulmonary pressure Ptp,regional for multiple lung regions of the patient P according to Equations 2 to 5:
P
ao(t)−Palv,regional(t)=RregionalVregional(t) Equation 2
P
tp,regional(t)=Palv,regional(t)−Ppl,regional(t)=El,regionalVregional(t) Equation 3
P
pl,regional(t)−Pmus(t)=Ecw,regionalVregional(t) Equation 4
P
tp,regional(t)=El,regionalVregional(t) Equation 5
wherein Palv,regional(t) [cm H2O] and Ppl,regional(t) [cm H2O] are the alveolar and pleural pressure of a specific lung region, respectively.
With reference to
At an operation 101, imaging data (i.e., the US imaging data 22) and ventilator (e.g., pressure or flow) data associated with lungs of the patient P are received at the mechanical ventilator 2. The acquiring operation 101 can occur while the patient undergoes mechanical ventilation therapy with the associated mechanical ventilator 2. The US imaging data 22 can comprise a mid-axillary intercostal approach at the zone of apposition, and/or a subcostal approach using the liver or spleen as an acoustic window (see, e.g., P. Tuinman et al. “Respiratory muscle ultrasonography: methodology, basic and advanced principles and clinical applications in ICU and ED patients—a narrative review”, Intensive Care Med. 2020). The intercostal approach allows for easy real-time measurement of the diaphragm thickness and strain, whereas the diaphragm excursion can be more easily measured with the subcostal approach. In another example, surface electromyography (EMG) data can be obtained from the patient P by measuring auxiliary respiratory muscle activities of the patient P.
At an operation 102, the received imaging data 22 and the received ventilator data are synchronized with respect to time. The mechanical ventilator 2 and the US imaging device 18 are two independent systems and often are from different manufacturers, which makes it a challenge to access clocks to synchronize them. Hence, these systems and the output data streams are often not synchronized. Also, additional synchronization processes may be needed since there still may be a delay between data measured by the mechanical ventilator 2 and the US imaging device 18. Surface EMG data, if acquired, can also be synchronized in the same manner with the the received imaging data 22 and/or the received ventilator data.
Diaphragm thickness, strain, and excursion correlate well with ventilator waveforms generated by the mechanical ventilator 2 and hence can be used to synchronize the US imaging data 22 with ventilator waveforms (e.g., pressure or flow). For example, in pressure support ventilation the pressure ramps up at the onset of the thickening of the diaphragm. A time delay between the ventilator waveform and the US imaging data 22 can be determined, for example, by cross-correlation or by applying a pre-trained machine learning algorithm. This delay can be applied to other US imaging data 22, for example, to measure lung sliding at various lung zones in order to synchronize these lung sliding measurements with the corresponding ventilator waveforms. The algorithm to determine the offset and to apply the offset to subsequent measurements can be run on the mechanical ventilator 2, on the US imaging device 18, on a separate processing unit or in the cloud.
Alternatively, diaphragm excursion could be used for synchronization. Also, a unique marker could be created for example with a gentle manual chest compression which results in specific features in the diaphragm thickness, strain and excursion and in the pressure and flow waveforms. In order to perform the synchronization procedure, the clinician could be asked to apply a chest compression within a certain time window (e.g., 10 s). This provides the time window in which the algorithm can search for the features to perform the synchronization. Feedback could be given to the caregiver in case of a successful synchronization or, in case the synchronization is not successful, the caregiver could be asked to repeat the chest compression. Other methods to provide unique markers could be through a dedicated breathing maneuver or the use of phrenic nerve stimulation to activate the diaphragm, e.g., with a unique pattern that could be searched for in the ultrasound and ventilator data by the algorithm. Also, one of the lung sliding measurements could be used to synchronize with the flow measured by the mechanical ventilator 2.
At an operation 103, a respiratory pressure of the lungs of the patient P is determined based on the received imaging data and the received ventilator data. This operation 103 corresponds to determining a pressure associated with the respiratory activity of the patient P. For example, the determined pressure corresponds to the driving pressure (i.e., Pao(t)−Pmus(t)) of Equation 1. To determine the driving respiratory pressure, the airway opening pressure Pao(t) is determined from the ventilator pressure data, and the respiratory muscle pressure Pmus(t) is determined from the US imaging data 22. The driving respiratory pressure is determined from the difference between Pao(t) and Pmus(t). Alternatively, the determined pressure corresponds to transpulmonary pressure of the patient P. In other examples, the determined pressure corresponds to any other pressure associated with respiratory of the patient, such as the respiratory muscle pressure Pmus(t), a pressure at an opening of the esophagus of the patient P (Pesophageal(t), alveolar pressure Palveolar(t), a combination of any of these, and so forth.
In general, the diaphragm is the dominant respiratory muscle and hence the contribution of the accessory muscles to Pmus can be neglected. For example, this can be done by the use of a force-length relation for muscle fibers where the length information is derived from the ultrasound measurements (see, e.g., Zhang et al. Biomechanical simulation of thorax deformation using finite element approach. BioMed Eng OnLine. 2016). Other methods can be employed to use ultrasound to assess and quantify the activity of the diaphragm. Diaphragm strain and strain rate correlate well with transdiaphragmatic pressure (see, e.g., E. Oppersma et al. Functional assessment of the diaphragm by speckle tracking ultrasound during inspiratory loading. J Appl Phys. 2017). The thickness fraction of the diaphragm corresponds well with the diaphragmatic pressure-time product (see, e.g., M. Umbrello et al. Diaphragm ultrasound as indicator of respiratory effort in critically ill patients undergoing assisted mechanical ventilation: a pilot clinical study. Crit Care. 2015). The thickness fraction (TFdi) is defined as the percentage inspiratory increase in the diaphragm thickness relative to end-expiratory thickness (Tee) during tidal breathing, as shown in Equation 2:
with Tei the end-inspiratory thickness. In some examples, the surface EMG data can assist in assessing the respiratory muscle pressure by measuring auxiliary respiratory muscle activities as an additional input. Surface EMG data synchronized with the imaging data 22 and/or the ventilator data can improve the accuracy of the respiratory muscle activities estimation.
It is also noted that in the case of a passive patient who is not exerting any respiratory effort (for example, a fully sedated patient), the respiratory muscle pressure Pmus(t) is equal to zero.
At an operation 104, a lung volume (i.e., the volume of inhaled gas Vregional(t)) and a lung flow (i.e., gas flow into a region of the lung Vregional(t)) for at least one region of the lungs of the patient P can be determined based on lung sliding data and the determined respiratory pressure of the lungs (i.e., the driving pressure). To determine the lung sliding data, additional imaging data 22 of each region of the lungs of the patient P is obtained and sliding waveforms for each region of the lungs of the patient P are generated from the additional imaging data 22. This operation 104 is repeated for each regional of the lungs of the patient P.
Lung sliding US measurements are obtained with the US imaging device 18 at various lung zones. The lung sliding is quantified and the lung sliding waveforms (i.e., one waveform per region of the lungs) are synchronized with the ventilator waveforms using the time delay determined at the operation 102.
Regional lung sliding depends on several parameters such as the regional lung resistance and compliance but also on global parameters such as the shape and size of the chest wall and the diaphragm. Also, it is important to know at which location the lung sliding is measured. For example, since the diaphragm expands the lung in downward direction while the lung is ‘fixated’ at the upper end the amount of lung sliding in the lower lung zones is expected to be larger than in the upper zones. To address this, the volume Vregional(t) and the flow Vregional(t) can be determined at each region of the lungs using a (biomechanical) model 30 of the lungs of the patient P with imaging data of dimensions of the lungs and diaphragm of the patient P. For example, the model 30 of the patient P can be generated from previously acquired imaging data (i.e., CT imaging data) and stored in the non-transitory computer readable medium 15 of the mechanical ventilator 2. The model 30 can be retrieved, and then used to determine the volume Vregional(t) and the flow Vregional(t) based on the imaging data of dimensions of the lungs and diaphragm of the patient P.
To construct the model 30, a machine learning model can be trained for each lung region using a data set comprising simultaneously recorded lung sliding data and CT images. Local volume changes can be derived from the CT images and serve as ground truth values for the training. For each region, local volume changes can be inferred by applying the trained machine learning model to patient specific lung sliding data from that specific region. Optionally, prior to use, the trained machine learning model is calibrated with patient specific CT images.
With continuing reference to
The generated sliding waveforms of each region of the lungs of the patient P can be used to determine a stress index for the at least one region of the lungs based on the lung sliding data and the driving respiratory pressure. To do so, the generated sliding waveforms of each region of the lungs of the patient P includes a regional stress index for each region of the lungs. In some examples, the mechanical ventilator 2 can be controlled to adjust one or more parameters of the mechanical ventilation therapy delivered to the patient P based on the generated lung sliding-time curves having the regional stress index. The generated lung sliding-time curves can be displayed on the display device 14 of the mechanical ventilator 2.
In case the driving pressure is not constant during inhalation (e.g., a non-zero Pmus(t) or a time-variable Pao(t)), several methods are proposed to indicate presence of (de)recruitment at exhalation and/or overdistension at inhalation. In one example, the driving pressure can be constructed from the measured ultrasound Pmus(t) and ventilator Pao(t) waveforms and the expected flow behaviour can be predicted based on a single compartment model with constant resistance and compliance values. Then, the expected lung sliding can be predicted from the biomechanical model 30 of the respiratory system and the predicted lung sliding behaviour can be compared with the measured lung sliding. A deviation between the measured and predicted lung sliding behaviour indicates presence of a volume-dependent compliance (assuming volume dependency of resistance to be small) which, depending on the sign and shape of the error curve, indicates presence of (de)recruitment or overdistension. In another example, a single compartment model can be fit with constant resistance and compliance values to the measured waveforms and split the fit residual in several portions throughout the breathing cycle. Depending on whether the fit residual increases or decreases presence of (de)recruitment or overdistension can be derived. In another example, the breathing cycle can be split in several portions to construct the biomechanical model 30 with different compliance values for each portion and fit this to the measured waveforms. The behaviour of the fitted time-variable compliance (different compliance values for each compartment) indicates presence of decruitment (increasing compliance) or overdistension (decreasing compliance).
In some examples, a presence of regional (de)recruitment or overdistension can be assessed from a regional pressure-volume loop. To this end, the regional volume is derived from lung sliding measurements and the biomechanical model 30. To construct the regional pressure-volume loop, a global transpulmonary pressure waveform is plotted against the regional volume waveform for one or more breathing cycles. The global transpulmonary pressure can be determined using known methods such as the use of esophageal pressure. Another method to construct the regional pressure-volume loop is by plotting a regional transpulmonary pressure waveform against the regional volume waveform for one or more breathing cycles. The regional transpulmonary pressure can be determined from the operation 106. Alternatively, information on regional (de)recruitment or overdistension is derived directly from a pressure-lung sliding loop. The information from the various regional pressure-volume loops is used to guide ventilation, e.g., PEEP and tidal volume level such that the majority of the lung regions are ventilated in the safe window or such that no or as little as possible lung regions show severe decruitment or overdistension.
Additionally, the regional pressure-volume (or -lung sliding) loop can be combined with additional information extracted from the US Imaging data 22 such as B-lines to identify a presence of atelectasis. For example, for several PEEP values, a regional pressure-volume loop could be constructed and for each PEEP setting the number of B-lines could be identified such as to provide information on optimum PEEP values. Similarly, these measurements could be combined with dynamic air bronchograms to identify decruitment
At an operation 106, a regional resistance (i.e., the resistance Rregional of a region of a lung) and a regional elastance (i.e., the elastance Eregional of the region of the lung) for the at least one region of the lungs of the patient P is determined from the lung volume Vregional(t) and the lung flow Vregional(t). To do so, the elastance Eregional is first determined when the lung flow Vregional(t) is zero (i.e., the resistive work is Equation 1 is zero). The elastance Eregional can then be determined by the driving respiratory pressure Pao(t)−Pmus(t) (from the operation 103) and the lung volume Vregional(t) (from the operation 104) by solving Equation 1. Once the elastance Eregional is known, Equation 1 can then be solved for the resistance Rregional based on the (non-zero) lung flow Vregional(t) determined from the operation 104.
In some embodiments, at the operation 106, a regional transpulmonary pressure for the at least one lung region is determined. To do so, an elastance of the chest wall Ecw,regional of a selected lung region is first determined, for example using an algorithm to compute the chest wall elastance based on a computed tomography (CT) scan. A finite element model of the region of the thorax can be constructed based on a segmentation of the CT scan (see, e.g., Zhang et al. BioMed Eng OnLine (2016) 15:18, “Biomechanical simulation of thorax deformation using finite element approach”). Known mechanical properties of the structures (intercostal muscle, diaphragm, bone, cartilage, tendons, and so forth) are input to the finite element model. The effective chest wall elastance of that region can be calculated by imposing a force F (or a pressure) in a direction perpendicular to the chest wall (as a boundary condition), and subsequently determine the simulated displacement x from the model output: Ecw,regional=F/x. Alternatively, the chest wall compliance can be assumed from values from a lookup table that uses known values.
Next, from Equation 4 the pleural pressure Ppl,regional(t) of the selected lung region is calculated from the chest wall elastance Ecw,regional, the lung volume Vregional(t) and respiratory muscle pressure Pmus(t). Then, from Equation 2 the alveolar pressure Palv,regional(t) of the selected lung region is calculated from the resistance Rregional, lung flow Vregional(t) and airway opening pressure Pao(t). Next, from Eregional=El,regional+Ecw,regional the lung elastance El,regional for the selected lung region is calculated. Finally, from Equation 3 the regional transpulmonary pressure Ptp,regional(t) is calculated from the pleural pressure Ppl,regional(t), alveolar pressure Palv,regional(t), lung elastance El,regional and lung volume Vregional(t).
The operation 106 can be performed in cases where Pmus is zero or non-zero. Diaphragmatic ultrasound can be used to verify that Pmus is zero, for example, by measuring the thickness fraction of the diaphragm (TFdi) at the intercostal space which should be zero or slightly negative due to passive stretching (see, e.g., Santana P V, Cardenas L Z, Albuquerque A L P, Carvalho C R R, Caruso P. Diaphragmatic ultrasound: a review of its methodological aspects and clinical uses. J Bras Pneumol. 2020 Nov. 20), or by constructing Pmus from a force-length relation for muscle fibers. There are several ways to estimate the regional compliance Cregional=1/Eregional. For example, the pressure at the airway Pao is measured by the ventilator at the end of inhalation and exhalation where the gas flow Vregional is zero such that the resistive work in Equation 1 is zero. Simultaneously, the regional volume Vregional(t) is derived from ultrasound-based lung sliding measurements (from the operation 105). Once the regional compliance is obtained, regional resistance can be estimated by applying Equation 1 on a part of the breathing cycle with non-zero gas flow Vregional. Also, other methods such as a least squares regression can be used.
A second case concerns an actively breathing patient where Pmus is nonzero. The approach to determine regional resistance and compliance is similar to the approach for the passive patient, where instead of Pmus equals zero, the Pmus waveform from the operation 102 is used as input to Equation 1. A similar approach could be used for each region of the lungs.
At an operation 107, the regional resistance Rregional and elastance Eregional for the at least one region of the lungs of the patient P can be displayed on the display device 14. In some embodiments, a graph 32 showing changes of the regional resistance and elastance for the at least one region of the lungs as a function of time can be displayed on the display device 14. In some examples, a user input can be provided to a portion of the displayed graph 32 (i.e., a user or clinician providing a finger tap to a portion of the graph 32), and additional information related to the portion of the graph 32 can be displayed where the user input was received (i.e., a clinician can provide a finger tap at, for example, a time of 5 seconds into the mechanical ventilation therapy to determine the resistance and elastance at the 5 second time mark).
The displayed graph 32 can be used to give feedback to the clinician. For example, a regional intrinsic PEEP (iPEEP) value can be detected from the lung sliding measurements. To this end, the regional lung sliding measurements are converted into regional flow measurements. Next, for each lung region the flow at end of exhalation is determined. If the end-of-exhalation flow is not zero, the ventilation settings are adapted such as to provide a longer exhalation time and again the regional end-of-exhalation flow is assessed. This is repeated until the end-of-exhalation flow is zero or does not decrease further.
For example, the effect of ventilation parameters such as PEEP levels on the presence of atelectasis/tidal recruitment and overdistension for the various lung zones to guide the ventilation therapy is visualized. Also, regional resistance and compliance values can be presented as function of time to see temporal changes in regional lung status. For example, in case the regional resistance is changing it could be suggested to provide a bronchodilator or to apply suctioning to remove mucus.
In another example, pendelluft can be detected from regional lung sliding. To this end, the US based lung sliding measurements need to be synchronized as in the operation 102. The regional lung sliding measurements are converted into regional flow measurements. From the various flow patterns the presence of pendelluft is detected. Alternatively, presence of pendelluft is detected directly from the (synchronized) lung sliding measurements.
At an operation 108, the mechanical ventilator 2 can be controlled to adjust one or more parameters of the mechanical ventilation therapy delivered to the patient P using the regional resistance Rregional and elastance Eregional.
The disclosure has been described with reference to the preferred embodiments. Modifications and alterations may occur to others upon reading and understanding the preceding detailed description. It is intended that the exemplary embodiment be construed as including all such modifications and alterations insofar as they come within the scope of the appended claims or the equivalents thereof.
This patent application claims the priority benefit under 35 U.S.C. § 119(e) of U.S. Provisional Application No. 63/426,069, filed on Nov. 17, 2022, the contents of which are herein incorporated by reference. The following relates generally to the respiratory therapy arts, respiratory stress and strain arts, Ventilator Induced Lung Injury (VILI) risk assessment arts, and related arts.
Number | Date | Country | |
---|---|---|---|
63426069 | Nov 2022 | US |